DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants
- PMID: 39324671
- PMCID: PMC11484294
- DOI: 10.1158/2767-9764.CRC-24-0257
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants
Abstract
This study describes associations between immune cell types and cancer risk in a Black population; elevated regulatory T-cell proportions that were associated with increased overall cancer and lung cancer risk, and elevated memory B-cell proportions that were associated with increased prostate and all cancer risk.
©2024 The Authors; Published by the American Association for Cancer Research.
Conflict of interest statement
C.S. Semancik reports grants from Jennifer M. Bjercke Scholar Award Fund for Breast Cancer Research at the Tufts Medical Center during the conduct of the study. E. Boerwinkle reports grants from NIH during the conduct of the study. J. Bressler reports grants from NIH/NHLBI during the conduct of the study. R.J. Buchsbaum reports grants and other from Jennifer M. Bjercke Scholar Award during the conduct of the study, grants from NIH/NHLBI 1R01CA243542 and NIH/NHLBI 1R01HL166810 outside the submitted work, as well as a patent number 11932650 issued. K.T. Kelsey reports a patent number 10,619,211 issued as well as being founder and scientific advisor for Cellintec outside the submitted work. E.A. Platz reports grants from National Cancer Institute during the conduct of the study, personal fees from the American Association for Cancer Research (AACR) outside the submitted work, as well as being an elected member of the AACR Board of Directors. D.S. Michaud reports grants from Jennifer M. Bjercke Scholar Award Fund for Breast Cancer Research at the Tufts Medical Center during the conduct of the study. No disclosures were reported by the other authors.
Figures
Update of
-
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk, Including Lung Cancer, in Black Participants.medRxiv [Preprint]. 2024 May 9:2024.05.09.24307118. doi: 10.1101/2024.05.09.24307118. medRxiv. 2024. Update in: Cancer Res Commun. 2024 Oct 1;4(10):2714-2723. doi: 10.1158/2767-9764.CRC-24-0257. PMID: 38766207 Free PMC article. Updated. Preprint.
References
-
- Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011;331:1565–70. - PubMed
-
- Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature 2017;541:321–30. - PubMed
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–74. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical